The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016)
Abstract
INTRODUCTION: Quinazoline and quinazolinone scaffolds represent an important class of biologically active nitrogen heterocyclic compounds. A variety of marketed drugs are based on these moieties. A diverse range of molecules with quinazoline/quinazolinone moieties have been reported to exhibit broad spectrum of biological activities. AREAS COVERED: This review covers recent efforts in the synthesis and biological screening of quinazoline/quinazolinone based compounds from 2011-2016. EXPERT OPINION: Quinazoline and quinazolinones represent a diverse class of biologically active nitrogen heterocyclic compounds with immense therapeutic potential. Their ease of synthetic accessibility, and flexibility in structural modifications and functionalization further adds to their appeal in medicinal chemistry. A number of currently available drugs are based on quinazoline/quinazolinone scaffold. It is interesting to note that, among the recent patents available, a lot of them focus on the promising anticancer activity of quinazoline and quinazolinone containing compounds. However their biological activity is certainly not limited to anticancer only, they are also known to elicit a number of other biological and physiological effects in vitro and in vivo respectively. The interest in quinazolines and quinazolinones is ever growing, since they offer a fairly diverse chemical space for exploration of medicinal potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., & Sims, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108190108 · Cited by 1,110
Taniguchi, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111849 · Cited by 336
Chlamydia trachomatis and chlamydia-like bacteria: new enemies of human pregnancies
Ammerdorffer, A., Stojanov, M., Greub, G., & Baud, D. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000369 · Cited by 57
Hu, J., Zhang, Y., Dong, L., Wang, Z., Chen, L., Liang, D., Shi, D., Shan, X., & Liang, G. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12454 · Cited by 55
Берест, Г. Г., Воскобойнік, О. Ю., Коваленко, С. І., Antypenko, O., Носуленко, И. С., Katsev, A. M., & Shandrovskaya, O. S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.10.022 · Cited by 47
Brahimi, F., Rachid, Z., Qiu, Q., McNamee, J. P., Li, Y., Tari, A. M., & Jean‐Claude, B. J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20383 · Cited by 29
Cited by
Xu, Z., Zhao, S.-J., & Liu, Y. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111700 · Cited by 520
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
Kumar, A., Singh, A. K., Singh, H., Vijayan, V., Kumar, D., Naik, J., Thareja, S., Yadav, J. P., Pathak, P., Grishina, M., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16020299 · Cited by 363
Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids
Auti, P. S., George, G., & Paul, A. T. (2020) · RSC Advances · doi:10.1039/d0ra06642g · Cited by 324
Metadata
- Authors
- Hameed, A., Al-Rashida, M., Uroos, M., Ali, S. A., Arshia, Ishtiaq, M., & Khan, K. M.
- Venue
- Expert Opinion on Therapeutic Patents
- Publisher
- Informa UK Limited
- Published
- 2018-02-05
- Volume
- 28
- Issue
- 4
- Pages
- 281-297
- ISSN
- 1354-3776 (ISSN-L)
- 1744-7674
- OpenAlex
- W2790161043
- Cited by
- 258
- References
- 7
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016). https://app.cochat.ai/papers/10.1080/13543776.2018.1432596
- The paper
- Hameed, A., Al-Rashida, M., Uroos, M., Ali, S. A., Arshia, Ishtiaq, M., & Khan, K. M. (2018). Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016). Expert Opinion on Therapeutic Patents. https://doi.org/10.1080/13543776.2018.1432596
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.